Harvest Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,000
Closed -$243K 67
2022
Q4
$243K Buy
+12,000
New +$184K 0.25% 35

Harvest Management's OPNT Position: Q1 2023 in Review

Harvest Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 12,000 shares — an estimated $243K sold.

Harvest Management first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $243K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • Harvest Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Harvest Management sold 12,000 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $243K.
  • Harvest Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Harvest Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $243K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Harvest Management's 13F filing for Q1 2023, filed 15 May 2023.